# Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children

> **NCT04542629** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 140 (estimated)

## Conditions studied

- Refractory Epilepsy

## Interventions

- **DRUG:** RiTUXimab Injection [Rituxan]

## Key facts

- **NCT ID:** NCT04542629
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2021-08-20
- **Final completion:** 2022-08-20
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04542629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04542629, "Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04542629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*